FORWARD PHARMA A/S
SPONSORD ADS NEW · CUSIP 34986J204
1
institutional holders
+0 vs Q3 2023
525
shares reported held*
$210.0kreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $400.00.
Trends to Q4 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 8 |
| Q4 2022 | 2 |
| Q1 2023 | 1 |
| Q2 2023 | 1 |
| Q3 2023 | 1 |
| Q4 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 6 |
| Q1 2023 | 0 | 1 |
| Q2 2023 | 0 | 1 |
| Q3 2023 | 0 | 0 |
| Q4 2023 | 0 | 0 |
Holders, Q4 2023
| Manager | Shares | Change |
|---|---|---|
| MASON CAPITAL MANAGEMENT LLC 0.02% of their portfolio | 525 $210.0k | Unchanged |